Alpha-1 Antitrypsin Deficiency

Assessment Data

Diagnosis

Outcomes

Interventions

Rationale

Evaluation

Wheezing

Excessive cough with phlegm

Dyspnoea

Ineffective breathing pattern related to bronchial tube spasms as evidenced by wheezing, excessive cough with phlegm and dyspnoea.

The patient will demonstrate and maintain an optimal breathing pattern within three days.

Administer medications such as short-acting beta-2-adrenergic agonists such as albuterol and terbutaline.

Administer inhaled corticosteroids such as beclomethasone and budesonide.

Educate the patient on therapeutic techniques such as maintaining the head of the bed elevated.

These medications act as bronchodilators; hence they aid in the relaxation of the muscles that line the airway carrying air to the lungs (Ackley et al., 2019).

Corticosteroids act by reducing inflammation of the airways carrying air to the lungs and reducing mucus production by bronchial tubes.

To promote the maximum expansion of the lungs hence assisting in breathing.

After three days of interventions, the patient demonstrated an optimal breathing pattern.

Lethargy

Decreased exercise capacity

Activity intolerance related to fatigue, as evidenced by lethargy and decreased exercise capacity (Ackley et al., 2019).

The patient will engage in daily activities without exhaustion within 48 hours.

Reinforce limitations to activity and exercise as they trigger fatigue.

This provides a therapeutic, preventive measure in offsetting fatigue and prevents changes in the patient's respiratory status as energy reserves are conserved.

After 48 hours, the patient engages in everyday activities without fatigue and exhaustion.

Restlessness

Apprehensiveness

Tachycardia

Anxiety related to the disease process and a change in health status as evidenced by restlessness, apprehensiveness, and tachycardia.

The patient will demonstrate an effective coping mechanism in 24 hours.

The patient will verbalize a decrease in anxiety level experience after 24 hours.

Provide suitable comfort measures such as a calm environment.

Explain procedures to the patient in a simple way.

Encourage deep, slow breathing and assure the client and significant others.

A calm environment reduces the consumption of oxygen.

Helping the client understand the treatment and procedures decreases anxiety levels (Ackley et al., 2019).

It ensures prompt intervention, and the presence of their significant others provides a sense of security to the client.

After 24 hours, the patient demonstrated an effective coping mechanism.

After 24 hours, the patient verbalizes a decreased anxiety.